D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 79 Citations 30,027 539 World Ranking 12205 National Ranking 32
Genetics D-index 73 Citations 25,478 369 World Ranking 1332 National Ranking 8

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Disease

Parkinson's disease, Genetics, Internal medicine, Disease and LRRK2 are his primary areas of study. His Parkinson's disease study incorporates themes from Apathy, Ashkenazi jews, Physical therapy and Restless legs syndrome. His research on Internal medicine frequently links to adjacent areas such as Gastroenterology.

His Disease research includes elements of Logistic regression, Bioinformatics, Phenotype, Inflammation and Cohort. His Case-control study research is multidisciplinary, incorporating perspectives in Odds ratio, Surgery, Genotype and Polysomnography. His Odds ratio research focuses on subjects like Genotyping, which are linked to Gene mutation.

His most cited work include:

  • Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease (1232 citations)
  • Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease (1232 citations)
  • Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. (438 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Parkinson's disease, Internal medicine, Disease, Genetics and LRRK2. His Parkinson's disease study is concerned with the field of Pathology as a whole. The various areas that Eng-King Tan examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology.

Eng-King Tan has researched Disease in several fields, including Genetic testing, Essential tremor, Gene and Pathogenesis. His research in LRRK2 intersects with topics in Kinase and Neurodegeneration. His Case-control study research includes themes of Odds ratio and Surgery.

He most often published in these fields:

  • Parkinson's disease (51.03%)
  • Internal medicine (45.13%)
  • Disease (44.10%)

What were the highlights of his more recent work (between 2018-2021)?

  • Disease (44.10%)
  • Parkinson's disease (51.03%)
  • Internal medicine (45.13%)

In recent papers he was focusing on the following fields of study:

His main research concerns Disease, Parkinson's disease, Internal medicine, Neuroscience and LRRK2. His study focuses on the intersection of Disease and fields such as Computational biology with connections in the field of Movement disorders. Eng-King Tan combines subjects such as Pathogenesis, Rating scale, Gait, Quality of life and Cognition with his study of Parkinson's disease.

His work focuses on many connections between Internal medicine and other disciplines, such as Oncology, that overlap with his field of interest in Allele and Stem cell. His Allele study combines topics from a wide range of disciplines, such as Genome-wide association study and Genotype. His work deals with themes such as Parkin, PINK1, Mutant and Cell biology, which intersect with LRRK2.

Between 2018 and 2021, his most popular works were:

  • Parkinson disease and the immune system - associations, mechanisms and therapeutics. (41 citations)
  • Parkinson disease and the immune system - associations, mechanisms and therapeutics. (41 citations)
  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) (38 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Internal medicine
  • Disease

Eng-King Tan mostly deals with Disease, Parkinson's disease, Neuroscience, Internal medicine and Neurodegeneration. His Disease study combines topics in areas such as Neurological signs, Demography, Clinical trial and Cohort. His research integrates issues of Gait and Proteostasis in his study of Parkinson's disease.

His studies deal with areas such as Chaperone and Protein degradation as well as Neuroscience. His study in Endocrinology extends to Internal medicine with its themes. His Neurodegeneration research incorporates themes from Reactive oxygen species, Dopamine and Pharmacology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif.
Autophagy (2021)

8964 Citations

Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease

Ellen Sidransky;Michael A. Nalls;Jan O. Aasly;Judith Aharon-Peretz.
The New England Journal of Medicine (2009)

1845 Citations

Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Demetrius M. Maraganore;Mariza De Andrade;Alexis Elbaz;Matthew J. Farrer.
JAMA (2006)

586 Citations

Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons

Junghyun Jo;Yixin Xiao;Alfred Xuyang Sun;Engin Cukuroglu.
Cell Stem Cell (2016)

530 Citations

Restless legs syndrome in an Asian population: A study in Singapore.

E.K. Tan;A. Seah;S.J. See;E. Lim.
Movement Disorders (2001)

372 Citations

Variability and validity of polymorphism association studies in Parkinson's disease.

E. K. Tan;M. Khajavi;J. I. Thornby;S. Nagamitsu.
Neurology (2000)

311 Citations

Pathogenic mutations in Parkinson disease

Eng-King Tan;Lisa M. Skipper.
Human Mutation (2007)

296 Citations

Botulinum toxin A in patients with oromandibular dystonia Long-term follow-up

Eng-King Tan;Joseph Jankovic.
Neurology (1999)

249 Citations

Case control study of diffusion tensor imaging in Parkinson’s disease

Ling-Ling Chan;Helmut Rumpel;Karen Yap;Esther Lee.
Journal of Neurology, Neurosurgery, and Psychiatry (2007)

235 Citations

Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese

E.-K. Tan;E.-K. Tan;C. Tan;S.M.C. Fook-Chong;S.Y. Lum.
Journal of the Neurological Sciences (2003)

231 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Eng-King Tan

Joseph Jankovic

Joseph Jankovic

Baylor College of Medicine

Publications: 131

Thomas Gasser

Thomas Gasser

University of Tübingen

Publications: 106

Matthew J. Farrer

Matthew J. Farrer

University of Florida

Publications: 97

Elan D. Louis

Elan D. Louis

The University of Texas Southwestern Medical Center

Publications: 89

Owen A. Ross

Owen A. Ross

Mayo Clinic

Publications: 81

Anthony H.V. Schapira

Anthony H.V. Schapira

University College London

Publications: 79

Daniela Berg

Daniela Berg

Kiel University

Publications: 77

Christine Klein

Christine Klein

University of Lübeck

Publications: 75

Guy A. Rouleau

Guy A. Rouleau

Montreal Neurological Institute and Hospital

Publications: 75

Ellen Sidransky

Ellen Sidransky

National Institutes of Health

Publications: 75

Andrew B. Singleton

Andrew B. Singleton

National Institutes of Health

Publications: 74

John Hardy

John Hardy

University College London

Publications: 71

Nobutaka Hattori

Nobutaka Hattori

Juntendo University

Publications: 63

Leonidas Stefanis

Leonidas Stefanis

National and Kapodistrian University of Athens

Publications: 63

Alexis Brice

Alexis Brice

Institut du Cerveau

Publications: 60

Zbigniew K. Wszolek

Zbigniew K. Wszolek

Mayo Clinic

Publications: 57

Trending Scientists

David Riaño

David Riaño

Spanish National Research Council

Blake LeBaron

Blake LeBaron

Brandeis University

Leyi Wei

Leyi Wei

Shandong University

Symeon Papavassiliou

Symeon Papavassiliou

National Technical University of Athens

Gad M. Landau

Gad M. Landau

University of Haifa

Cary L. Pint

Cary L. Pint

Iowa State University

Wei Xiao

Wei Xiao

University of Saskatchewan

Bao-Rong Lu

Bao-Rong Lu

Fudan University

Ian M. Head

Ian M. Head

Newcastle University

Kathryn Roeder

Kathryn Roeder

Carnegie Mellon University

Andrew C. Allan

Andrew C. Allan

Plant & Food Research

Raymond C. Sowder

Raymond C. Sowder

National Cancer Institute

Cathleen C. Piazza

Cathleen C. Piazza

Rutgers, The State University of New Jersey

Stanley L. Deno

Stanley L. Deno

University of Minnesota

Jim Todd

Jim Todd

London School of Hygiene & Tropical Medicine

Ronald B. Hirschl

Ronald B. Hirschl

University of Michigan–Ann Arbor

Something went wrong. Please try again later.